Press Release - Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions
Zenodo (CERN European Organization for Nuclear Research) December 17, 2024 University Medical Center Groningen
A clinical trial called PsyPal, which tests psilocybin-assisted therapy for psychological distress in palliative care, has received medical ethical authorization under EU regulations, with conditions, in participating member states. The multi-site study involves 19 partners across nine European countries and is coordinated by the University Medical Centre Groningen. It will evaluate the safety and efficacy of psilocybin therapy for patients with progressive, incurable diseases such as COPD, multiple sclerosis, ALS, and atypical Parkinsonism and advanced Parkinson's disease. The announcement clarifies the regulatory status and outlines next steps before patient recruitment begins.